Clinical Trial Update: A Study of the Safety and Effectiveness of Infliximab in Patients With Plaque-type Psoriasis [Phase 3]

View source ↗

Summary

This entry reports the completion of a Phase 3 trial assessing the safety and effectiveness of infliximab in plaque psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parapsoriasis
• Plaque Psoriasis

Drugs mentioned

• Infliximab (infliximab)

Snippet

Sponsor: Centocor, Inc. | Conditions: Psoriasis, Parapsoriasis | Phase 3 | Status: COMPLETED